Biolase, Inc. (BIOL) financial statements (2022 and earlier)

Company profile

Business Address 27042 TOWNE CENTRE DRIVE
FOOTHILL RANCH, CA 92610
State of Incorp. DE
Fiscal Year End December 31
SIC 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments29,97233,38537,08140,84217,56418,8475,437
Cash and cash equivalents29,97233,38537,08140,84217,56418,8475,437
Restricted cash and investments203204204204312312312
Receivables4,2383,6373,8193,2663,0593,3934,119
Inventory, net of allowances, customer advances and progress billings12,92914,06212,71511,87711,15712,59211,932
Inventory12,92914,06212,71511,87711,15712,59211,932
Prepaid expense680   947  
Other current assets1,332   573  
Other undisclosed current assets 1,3661,5211,5601,4989031,094
Total current assets:49,35452,65455,34057,74935,11036,04722,894
Noncurrent Assets
Operating lease, right-of-use asset1,7171,8231,8421,8901,9762,061649
Property, plant and equipment1,067889916693782742781
Intangible assets, net (including goodwill)2,9262,9262,9262,9262,9262,9262,926
Goodwill2,9262,9262,9262,9262,9262,9262,926
Other noncurrent assets220222225226231220506
Total noncurrent assets:5,9305,8605,9095,7355,9155,9494,862
TOTAL ASSETS:55,28458,51461,24963,48441,02541,99627,756
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,5859,7799,9639,3099,3186,8716,059
Accounts payable3,3093,5973,5023,0722,6512,5922,510
Accrued liabilities8,2766,1826,4616,2376,6674,2793,549
Deferred revenue2,2592,2782,0561,9611,9051,6161,486
Debt 1,400700  12,94613,544
Total current liabilities:13,84413,45712,71911,27011,22321,43321,089
Noncurrent Liabilities
Long-term debt and lease obligation15,05213,67114,30517,98117,9604,999 
Long-term debt, excluding current maturities13,60312,11412,70316,29516,1863,140 
Operating lease, liability1,4491,5571,6021,6861,7741,859 
Liabilities, other than long-term debt1,1801,0649697171,8141,7132,218
Accounts payable and accrued liabilities521472507297384204194
Deferred revenue329294333343374412412
Other liabilities330298129771,0561,0971,612
Other undisclosed noncurrent liabilities      3,140
Total noncurrent liabilities:16,23214,73515,27418,69819,7746,7125,358
Total liabilities:30,07628,19227,99329,96830,99728,14526,447
Temporary equity, carrying amount25,208      
Stockholders' equity
Stockholders' equity attributable to parent25,20830,32233,25633,51610,02813,8511,309
Preferred stock34343536118141 
Common stock154153151149989350
Additional paid in capital293,177292,948292,517292,141261,573259,385247,155
Accumulated other comprehensive loss(623)(558)(468)(533)(385)(534)(645)
Accumulated deficit(267,534)(262,255)(258,979)(258,277)(251,376)(245,234)(245,251)
Other undisclosed stockholders' equity(25,208)      
Total stockholders' equity: 30,32233,25633,51610,02813,8511,309
TOTAL LIABILITIES AND EQUITY:55,28458,51461,24963,48441,02541,99627,756

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues12,4089,5319,1348,1168,5206,5392,938
Cost of revenue(7,502)(4,689)(5,093)(5,375)(6,915)(4,265)(1,997)
Gross profit:4,9064,8424,0412,7411,6052,274941
Operating expenses(9,336)(7,499)(7,324)(8,803)(7,144)(5,941)(4,920)
Operating loss:(4,430)(2,657)(3,283)(6,062)(5,539)(3,667)(3,979)
Nonoperating income (expense)(1,453)(605)(2,501)779(524)3,694(665)
Investment income, nonoperating    64,209 
Foreign currency transaction gain (loss), before tax28036692044753(40)
Interest and debt expense4,714(600)(600)(95)(91)  
Income (loss) from continuing operations before equity method investments, income taxes:(1,169)(3,862)(6,384)(5,378)(6,154)27(4,644)
Other undisclosed income (loss) from continuing operations before income taxes(4,038)6005,602(1,463)91  
Income (loss) from continuing operations before income taxes:(5,207)(3,262)(782)(6,841)(6,063)27(4,644)
Income tax expense (benefit)(58)1480(60)(79)(15)(53)
Income (loss) before gain (loss) on sale of properties:(5,265)(3,248)(702)(6,901)(6,142)12(4,697)
Other undisclosed net loss(14)      
Net income (loss):(5,279)(3,248)(702)(6,901)(6,142)12(4,697)
Other undisclosed net loss attributable to parent (28)     
Net income (loss) attributable to parent:(5,279)(3,276)(702)(6,901)(6,142)12(4,697)
Preferred stock dividends and other adjustments     (17,378) 
Other undisclosed net loss available to common stockholders, basic (9)(6)(532)   
Net loss available to common stockholders, diluted:(5,279)(3,285)(708)(7,433)(6,142)(17,366)(4,697)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(5,279)(3,248)(702)(6,901)(6,142)12(4,697)
Comprehensive income (loss):(5,279)(3,248)(702)(6,901)(6,142)12(4,697)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(65)(118)65(148)14911174
Comprehensive income (loss), net of tax, attributable to parent:(5,344)(3,366)(637)(7,049)(5,993)123(4,623)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: